Common Drug Could FIGHT Severe COVID-19 Cases

If you only read one article this week, this should be it.

It could give you a fighting chance in the COVID-19 era.

A new study shows that a certain drug can reduce deaths among patients with severe cases of COVID-19.

This is the among the FIRST drugs to show a fighting chance for coronavirus patients

It’s popular, and its dirt cheap… coming in at less than $65.

And it’s available NOW.

If you have COVID-19 and you’re put on a ventilator, your odds of surviving might not be very good.

But that could be about to change…

Researchers have identified a very inexpensive drug that might improve survival rates in the sickest patients with COVID-19.

The double-blind trial included about 6,500 COVID-19 patients. Some received the drug dexamethasone and the rest did not.

Dexamethasone is a steroid drug used to reduce inflammation in conditions like arthritis.

The results showed that dexamethasone reduced deaths among the most severely ill by nearly ONE THIRD.

It is suggested that dexamethasone could save one life for every eight COVID-19 patients on a ventilator, and for every 25 patients on oxygen

There was no benefit for COVID-19 patients who did not require respiratory support, indicating its benefits for just the sickest of the sick.

The same study also found that the malaria drug hydroxychloroquine had no benefit.

And as of this writing, dexamethasone is among the first drugs that has been shown to reduce mortality among COVID-19 patients.

These results are so strong that the researchers in Britain are suggesting that dexamethasone immediately become the standard of care for patients with severe cases of coronavirus in their hospital

I couldn’t agree more.

If you or a loved one becomes infected, be sure to show this study to your doctor.

Per the backup, I made a slight tweak to cover us. Is this OK with you?

The results suggest that one death would be prevented by treatment with dexamethasone among every eight ventilated COVID-19 patients,

Landray said, and one death would be prevented among every 25 COVID-19 patients that received the drug and are on oxygen.